BioCentury | Jun 22, 2020
Finance

In a first for the British Business Bank, firm backs Epidarex’s new fund

...coming from LPs such as the University of Edinburgh, University of Manchester, University of Glasgow, University of Aberdeen...
BioCentury | Jul 13, 2018
Clinical News

Cold Harbor JV developing copper chelator for Wilson's disease

...to study author and Professor Nicholas Tonks. Last November, a Cancer Research study from the University of Aberdeen...
BioCentury | Apr 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

...on CLEC1A could help predict the risk of Aspergillus infections in stem cell transplant recipients. University of Aberdeen...
BioCentury | Mar 7, 2018
Distillery Techniques

Biomarkers

...published online Feb. 28, 2018 doi:10.1038/nature25974 CONTACT: Gordon Brown, University of Aberdeen, Aberdeen, U.K. email: gordon.brown@abdn.ac.uk Allison Johnson University of Aberdeen C-type...
BioCentury | Dec 15, 2017
Tools & Techniques

Caveat fermentor

...the Cell Reports paper focused on artifacts arising from inappropriate experimental controls. According to the University of Aberdeen...
...Mass. Catholic University Leuven, Leuven, Belgium Harvard Medical School, Boston, Mass. RondinX, Tel Aviv, Israel University of Aberdeen...
...Innovations ( 2017) Mark Zipkin, Staff Writer and Karen Tkach Tuzman, Senior Writer Boston Children's Hospital Harvard Medical School RondinX University of Aberdeen KU...
BioCentury | Nov 16, 2017
Preclinical News

Disease targets also act as tumor suppressors

...NHL) and relapsed small lymphocytic lymphoma (SLL). Another study published in Cancer Research from the University of Aberdeen...
...antisense inhibitor targeting glucagon receptor (GCGR). Allison Johnson idelalisib IONIS-GCCRRx IONIS-PTP1BRx Keytruda nivolumab Opdivo pembrolizumab Gilead Sciences Inc. Ionis Pharmaceuticals Inc. Merck & Co. Inc. Technical University Munich University of Aberdeen Bristol...
BioCentury | Jun 15, 2017
Tools & Techniques

Breaking the barrier

...delivery platform, dubbed Shuttle, with target-binding small proteins from Elasmogen, a 2016 spinout from the University of Aberdeen...
...Inc., Daejeon, South Korea PEP-Therapy S.A.S., Evry, France Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. University of Aberdeen...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Ltd. Preclinical £1.2M ($1.5M) (B) Aberdeen, U.K. soloMERs, humanized shark variable new antigen receptors (VNARs) University of Aberdeen...
BioCentury | May 12, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...financial terms or additional information for the two targets. Elasmogen was spun out of the University of Aberdeen...
BioCentury | May 9, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...of its soloMER candidates to treat eye inflammatory disease. Elasmogen was spun out of the University of Aberdeen...
Items per page:
1 - 10 of 32
BioCentury | Jun 22, 2020
Finance

In a first for the British Business Bank, firm backs Epidarex’s new fund

...coming from LPs such as the University of Edinburgh, University of Manchester, University of Glasgow, University of Aberdeen...
BioCentury | Jul 13, 2018
Clinical News

Cold Harbor JV developing copper chelator for Wilson's disease

...to study author and Professor Nicholas Tonks. Last November, a Cancer Research study from the University of Aberdeen...
BioCentury | Apr 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

...on CLEC1A could help predict the risk of Aspergillus infections in stem cell transplant recipients. University of Aberdeen...
BioCentury | Mar 7, 2018
Distillery Techniques

Biomarkers

...published online Feb. 28, 2018 doi:10.1038/nature25974 CONTACT: Gordon Brown, University of Aberdeen, Aberdeen, U.K. email: gordon.brown@abdn.ac.uk Allison Johnson University of Aberdeen C-type...
BioCentury | Dec 15, 2017
Tools & Techniques

Caveat fermentor

...the Cell Reports paper focused on artifacts arising from inappropriate experimental controls. According to the University of Aberdeen...
...Mass. Catholic University Leuven, Leuven, Belgium Harvard Medical School, Boston, Mass. RondinX, Tel Aviv, Israel University of Aberdeen...
...Innovations ( 2017) Mark Zipkin, Staff Writer and Karen Tkach Tuzman, Senior Writer Boston Children's Hospital Harvard Medical School RondinX University of Aberdeen KU...
BioCentury | Nov 16, 2017
Preclinical News

Disease targets also act as tumor suppressors

...NHL) and relapsed small lymphocytic lymphoma (SLL). Another study published in Cancer Research from the University of Aberdeen...
...antisense inhibitor targeting glucagon receptor (GCGR). Allison Johnson idelalisib IONIS-GCCRRx IONIS-PTP1BRx Keytruda nivolumab Opdivo pembrolizumab Gilead Sciences Inc. Ionis Pharmaceuticals Inc. Merck & Co. Inc. Technical University Munich University of Aberdeen Bristol...
BioCentury | Jun 15, 2017
Tools & Techniques

Breaking the barrier

...delivery platform, dubbed Shuttle, with target-binding small proteins from Elasmogen, a 2016 spinout from the University of Aberdeen...
...Inc., Daejeon, South Korea PEP-Therapy S.A.S., Evry, France Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. University of Aberdeen...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Ltd. Preclinical £1.2M ($1.5M) (B) Aberdeen, U.K. soloMERs, humanized shark variable new antigen receptors (VNARs) University of Aberdeen...
BioCentury | May 12, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...financial terms or additional information for the two targets. Elasmogen was spun out of the University of Aberdeen...
BioCentury | May 9, 2017
Company News

Amgen developing intracellular therapies with Elasmogen, Feldan

...of its soloMER candidates to treat eye inflammatory disease. Elasmogen was spun out of the University of Aberdeen...
Items per page:
1 - 10 of 32